Rank | Gene Set | Z-score |
---|---|---|
1 | nuclear pore complex assembly (GO:0051292) | 6.41482345 |
2 | nuclear pore organization (GO:0006999) | 5.71691129 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.29547333 |
4 | L-phenylalanine catabolic process (GO:0006559) | 5.29547333 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.95700589 |
6 | L-phenylalanine metabolic process (GO:0006558) | 4.95700589 |
7 | mitotic sister chromatid cohesion (GO:0007064) | 4.83229087 |
8 | alpha-linolenic acid metabolic process (GO:0036109) | 4.67371850 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.56464732 |
10 | aromatic amino acid family catabolic process (GO:0009074) | 4.55744408 |
11 | pore complex assembly (GO:0046931) | 4.49430361 |
12 | kynurenine metabolic process (GO:0070189) | 4.27112281 |
13 | urea metabolic process (GO:0019627) | 4.26284449 |
14 | urea cycle (GO:0000050) | 4.26284449 |
15 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.13371847 |
16 | lysine metabolic process (GO:0006553) | 4.12547717 |
17 | lysine catabolic process (GO:0006554) | 4.12547717 |
18 | regulation of relaxation of muscle (GO:1901077) | 4.10934117 |
19 | bile acid biosynthetic process (GO:0006699) | 4.10050404 |
20 | cysteine metabolic process (GO:0006534) | 4.06785186 |
21 | indole-containing compound catabolic process (GO:0042436) | 3.91044375 |
22 | indolalkylamine catabolic process (GO:0046218) | 3.91044375 |
23 | tryptophan catabolic process (GO:0006569) | 3.91044375 |
24 | cardiac muscle hypertrophy (GO:0003300) | 3.89697003 |
25 | serine family amino acid catabolic process (GO:0009071) | 3.89657530 |
26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.86664825 |
27 | sulfur amino acid catabolic process (GO:0000098) | 3.84344835 |
28 | complement activation, alternative pathway (GO:0006957) | 3.80452478 |
29 | glutamate metabolic process (GO:0006536) | 3.80441588 |
30 | nitrogen cycle metabolic process (GO:0071941) | 3.78882983 |
31 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.78299465 |
32 | regulation of cholesterol homeostasis (GO:2000188) | 3.76752381 |
33 | negative regulation of fibrinolysis (GO:0051918) | 3.72702440 |
34 | high-density lipoprotein particle remodeling (GO:0034375) | 3.71591393 |
35 | tryptophan metabolic process (GO:0006568) | 3.71428456 |
36 | glyoxylate metabolic process (GO:0046487) | 3.70091259 |
37 | regulation of protein activation cascade (GO:2000257) | 3.67495600 |
38 | 2-oxoglutarate metabolic process (GO:0006103) | 3.67041911 |
39 | protein carboxylation (GO:0018214) | 3.65104143 |
40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.65104143 |
41 | bile acid metabolic process (GO:0008206) | 3.64698105 |
42 | striated muscle hypertrophy (GO:0014897) | 3.63878247 |
43 | cellular ketone body metabolic process (GO:0046950) | 3.61292751 |
44 | V(D)J recombination (GO:0033151) | 3.60266598 |
45 | DNA unwinding involved in DNA replication (GO:0006268) | 3.56155343 |
46 | pre-miRNA processing (GO:0031054) | 3.55750221 |
47 | homocysteine metabolic process (GO:0050667) | 3.53698859 |
48 | regulation of triglyceride catabolic process (GO:0010896) | 3.49803829 |
49 | valine metabolic process (GO:0006573) | 3.49328063 |
50 | amino-acid betaine metabolic process (GO:0006577) | 3.47781256 |
51 | regulation of histone H3-K9 methylation (GO:0051570) | 3.47630441 |
52 | regulation of fibrinolysis (GO:0051917) | 3.45460373 |
53 | definitive hemopoiesis (GO:0060216) | 3.45027102 |
54 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.44723541 |
55 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.44014827 |
56 | negative regulation of sterol transport (GO:0032372) | 3.42885402 |
57 | negative regulation of cholesterol transport (GO:0032375) | 3.42885402 |
58 | regulation of complement activation (GO:0030449) | 3.42703478 |
59 | triglyceride homeostasis (GO:0070328) | 3.40918628 |
60 | acylglycerol homeostasis (GO:0055090) | 3.40918628 |
61 | phospholipid efflux (GO:0033700) | 3.39512779 |
62 | alpha-amino acid catabolic process (GO:1901606) | 3.36092196 |
63 | reverse cholesterol transport (GO:0043691) | 3.32781795 |
64 | DNA double-strand break processing (GO:0000729) | 3.32120509 |
65 | short-chain fatty acid metabolic process (GO:0046459) | 3.28174397 |
66 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 3.24131584 |
67 | tyrosine metabolic process (GO:0006570) | 3.23117754 |
68 | ethanol oxidation (GO:0006069) | 3.23011035 |
69 | drug catabolic process (GO:0042737) | 3.22696931 |
70 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.22535537 |
71 | phospholipid homeostasis (GO:0055091) | 3.20721221 |
72 | negative regulation of histone acetylation (GO:0035067) | 3.18922410 |
73 | positive regulation of lipid catabolic process (GO:0050996) | 3.15591353 |
74 | cellular modified amino acid catabolic process (GO:0042219) | 3.15246785 |
75 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.15067846 |
76 | non-recombinational repair (GO:0000726) | 3.15067846 |
77 | cellular amino acid catabolic process (GO:0009063) | 3.14769571 |
78 | aromatic amino acid family metabolic process (GO:0009072) | 3.13758388 |
79 | protein-lipid complex remodeling (GO:0034368) | 3.13532037 |
80 | macromolecular complex remodeling (GO:0034367) | 3.13532037 |
81 | plasma lipoprotein particle remodeling (GO:0034369) | 3.13532037 |
82 | ketone body metabolic process (GO:1902224) | 3.11806507 |
83 | fatty acid transmembrane transport (GO:1902001) | 3.10708927 |
84 | acetyl-CoA metabolic process (GO:0006084) | 3.10153493 |
85 | ribosome assembly (GO:0042255) | 3.07332437 |
86 | regulation of bile acid biosynthetic process (GO:0070857) | 3.07312151 |
87 | cardiac muscle adaptation (GO:0014887) | 3.06249795 |
88 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.06249795 |
89 | muscle hypertrophy in response to stress (GO:0003299) | 3.06249795 |
90 | muscle hypertrophy (GO:0014896) | 3.03989650 |
91 | bile acid and bile salt transport (GO:0015721) | 3.03350673 |
92 | cholesterol efflux (GO:0033344) | 3.02757900 |
93 | fatty acid homeostasis (GO:0055089) | 3.02654551 |
94 | aspartate family amino acid catabolic process (GO:0009068) | 3.02435767 |
95 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.01538062 |
96 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.00840960 |
97 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.99329829 |
98 | plasma lipoprotein particle clearance (GO:0034381) | 2.98625923 |
99 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.98502443 |
100 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.97609950 |
101 | plasma lipoprotein particle assembly (GO:0034377) | 2.97543471 |
102 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.95495338 |
103 | mitotic chromosome condensation (GO:0007076) | 2.95126869 |
104 | muscle filament sliding (GO:0030049) | 2.94411218 |
105 | actin-myosin filament sliding (GO:0033275) | 2.94411218 |
106 | regulation of DNA endoreduplication (GO:0032875) | 2.93041974 |
107 | negative regulation of protein acetylation (GO:1901984) | 2.90738487 |
108 | histone mRNA catabolic process (GO:0071044) | 2.88775640 |
109 | myofibril assembly (GO:0030239) | 2.88772619 |
110 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.88001687 |
111 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.88001687 |
112 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.88001687 |
113 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.86986685 |
114 | carnitine shuttle (GO:0006853) | 2.85478154 |
115 | positive regulation of chromosome segregation (GO:0051984) | 2.84883583 |
116 | glycine metabolic process (GO:0006544) | 2.84651628 |
117 | protein-lipid complex assembly (GO:0065005) | 2.84149351 |
118 | NADH metabolic process (GO:0006734) | 2.83951142 |
119 | regulation of centriole replication (GO:0046599) | 2.83893962 |
120 | sister chromatid segregation (GO:0000819) | 2.83500977 |
121 | regulation of gamma-delta T cell activation (GO:0046643) | 2.83475742 |
122 | regulation of Rac protein signal transduction (GO:0035020) | 2.82384303 |
123 | genitalia morphogenesis (GO:0035112) | 2.81463305 |
124 | negative regulation of lipase activity (GO:0060192) | 2.81101247 |
125 | exogenous drug catabolic process (GO:0042738) | 2.79782507 |
126 | protein K11-linked deubiquitination (GO:0035871) | 2.79462270 |
127 | striated muscle contraction (GO:0006941) | 2.79222875 |
128 | regulation of cholesterol esterification (GO:0010872) | 2.78055628 |
129 | positive regulation of fatty acid oxidation (GO:0046321) | 2.77301831 |
130 | negative regulation of DNA recombination (GO:0045910) | 2.76908057 |
131 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.76347992 |
132 | cellular glucuronidation (GO:0052695) | 2.75896829 |
133 | cardiac muscle contraction (GO:0060048) | 2.75889553 |
134 | serine family amino acid metabolic process (GO:0009069) | 2.74513986 |
135 | regulation of actin filament-based movement (GO:1903115) | 2.74474795 |
136 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.74464316 |
137 | coenzyme catabolic process (GO:0009109) | 2.73974871 |
138 | fatty acid oxidation (GO:0019395) | 2.71319586 |
139 | linoleic acid metabolic process (GO:0043651) | 2.71144505 |
140 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.69058345 |
141 | acylglycerol catabolic process (GO:0046464) | 2.69014563 |
142 | neutral lipid catabolic process (GO:0046461) | 2.69014563 |
143 | fatty acid beta-oxidation (GO:0006635) | 2.68345351 |
144 | relaxation of cardiac muscle (GO:0055119) | 2.68332368 |
145 | histone H3-K9 demethylation (GO:0033169) | 2.67857884 |
146 | histone-serine phosphorylation (GO:0035404) | 2.67588050 |
147 | megakaryocyte development (GO:0035855) | 2.67351836 |
148 | indolalkylamine metabolic process (GO:0006586) | 2.65072748 |
149 | lipid oxidation (GO:0034440) | 2.64977956 |
150 | organic acid catabolic process (GO:0016054) | 2.64922537 |
151 | carboxylic acid catabolic process (GO:0046395) | 2.64922537 |
152 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.63935669 |
153 | cytolysis (GO:0019835) | 2.63680724 |
154 | mitotic nuclear envelope disassembly (GO:0007077) | 2.62695079 |
155 | tricarboxylic acid cycle (GO:0006099) | 2.62692943 |
156 | cholesterol homeostasis (GO:0042632) | 2.62684659 |
157 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.62344483 |
158 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.62138743 |
159 | mitochondrial DNA replication (GO:0006264) | 2.60529335 |
160 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.59270902 |
161 | peptidyl-threonine phosphorylation (GO:0018107) | 2.58713186 |
162 | regulation of protein glycosylation (GO:0060049) | 2.57784310 |
163 | sister chromatid cohesion (GO:0007062) | 2.57549967 |
164 | mitotic metaphase plate congression (GO:0007080) | 2.57002764 |
165 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.56812158 |
166 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.56606200 |
167 | membrane disassembly (GO:0030397) | 2.55772368 |
168 | nuclear envelope disassembly (GO:0051081) | 2.55772368 |
169 | negative regulation of histone methylation (GO:0031061) | 2.55718199 |
170 | cell communication by electrical coupling (GO:0010644) | 2.55577903 |
171 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.55041902 |
172 | DNA topological change (GO:0006265) | 2.53030652 |
173 | cell communication involved in cardiac conduction (GO:0086065) | 2.49991546 |
174 | mitotic G2/M transition checkpoint (GO:0044818) | 2.49208346 |
175 | cardiac myofibril assembly (GO:0055003) | 2.46229234 |
176 | IMP metabolic process (GO:0046040) | 2.45461992 |
177 | regulation of sister chromatid segregation (GO:0033045) | 2.44918791 |
178 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.44918791 |
179 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.44918791 |
180 | metaphase plate congression (GO:0051310) | 2.44561917 |
181 | regulation of chromosome segregation (GO:0051983) | 2.44252507 |
182 | DNA duplex unwinding (GO:0032508) | 2.43346776 |
183 | negative regulation of histone modification (GO:0031057) | 2.43079449 |
184 | skeletal muscle contraction (GO:0003009) | 2.42380550 |
185 | striated muscle adaptation (GO:0014888) | 2.42060284 |
186 | actin-mediated cell contraction (GO:0070252) | 2.41509966 |
187 | regulation of cell communication by electrical coupling (GO:0010649) | 2.41291208 |
188 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.41086430 |
189 | glucan catabolic process (GO:0009251) | 2.40568652 |
190 | glycogen catabolic process (GO:0005980) | 2.40543394 |
191 | regulation of meiosis I (GO:0060631) | 2.39658616 |
192 | spindle checkpoint (GO:0031577) | 2.38205420 |
193 | DNA geometric change (GO:0032392) | 2.37222357 |
194 | relaxation of muscle (GO:0090075) | 2.36958447 |
195 | positive regulation of macroautophagy (GO:0016239) | 2.36215463 |
196 | regulation of cofactor metabolic process (GO:0051193) | 2.35994336 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.15013980 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.85367330 |
3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.04695304 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.41984410 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.38532184 |
6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.66964979 |
7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.17761908 |
8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.09717934 |
9 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.98756754 |
10 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.98311497 |
11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.90627789 |
12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.85136967 |
13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.67604783 |
14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.65017153 |
15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.28612535 |
16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.10704754 |
17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.09463042 |
18 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.00485326 |
19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.99329794 |
20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.95474860 |
21 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.93417881 |
22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.91630937 |
23 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85466005 |
24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79967477 |
25 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.77580624 |
26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.75822321 |
27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.74173353 |
28 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.66773410 |
29 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.66093538 |
30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.65937522 |
31 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.63875026 |
32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.63443259 |
33 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.62524214 |
34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.61360806 |
35 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.59531344 |
36 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.55752257 |
37 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55259830 |
38 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52756533 |
39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.52339290 |
40 | EWS_26573619_Chip-Seq_HEK293_Human | 1.51965955 |
41 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.51772177 |
42 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.51245026 |
43 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50380873 |
44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49156664 |
45 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.48727967 |
46 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.48578722 |
47 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.45664779 |
48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.45101053 |
49 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.44384813 |
50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44360279 |
51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.44028096 |
52 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41338571 |
53 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40757650 |
54 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.40517931 |
55 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.40163640 |
56 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.39074035 |
57 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.38073833 |
58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34859129 |
59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31787510 |
60 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30956075 |
61 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.30483511 |
62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30397770 |
63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28836478 |
64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28741917 |
65 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.28633845 |
66 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25514919 |
67 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.25154972 |
68 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24649361 |
69 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.23605038 |
70 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.22626401 |
71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.22501890 |
72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21144823 |
73 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20866161 |
74 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.20607371 |
75 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19314449 |
76 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16901594 |
77 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.16817063 |
78 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.16175438 |
79 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15266201 |
80 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15074689 |
81 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.14387108 |
82 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14379955 |
83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14082084 |
84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13673669 |
85 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11902375 |
86 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.11657878 |
87 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11229039 |
88 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11061450 |
89 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10770723 |
90 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09905361 |
91 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09851096 |
92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09615485 |
93 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09146951 |
94 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07793543 |
95 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07303928 |
96 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.07195074 |
97 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07085488 |
98 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07025443 |
99 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.06984011 |
100 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05729145 |
101 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05620758 |
102 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.05478786 |
103 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05390111 |
104 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.05134389 |
105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04984432 |
106 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.04710875 |
107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04160768 |
108 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04058075 |
109 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03385378 |
110 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03336515 |
111 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02986277 |
112 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02942270 |
113 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02866845 |
114 | MYC_22102868_ChIP-Seq_BL_Human | 1.02833541 |
115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02809056 |
116 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02725168 |
117 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00552516 |
118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99996825 |
119 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.99755762 |
120 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99224426 |
121 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97583653 |
122 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97583653 |
123 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97312744 |
124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96772061 |
125 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.96160300 |
126 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95795085 |
127 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95139222 |
128 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.94045778 |
129 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93219147 |
130 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.93159199 |
131 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93069064 |
132 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.92909608 |
133 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92520115 |
134 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91095542 |
135 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.90803184 |
136 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90539554 |
137 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.90174617 |
138 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.89809191 |
139 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89261396 |
140 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.89246717 |
141 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.89019206 |
142 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.88622355 |
143 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.87975169 |
144 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87898571 |
145 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.87495239 |
146 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87449149 |
147 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86703916 |
148 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.86315585 |
149 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86179180 |
150 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.85911023 |
151 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85881528 |
152 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.85692892 |
153 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85070461 |
154 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.84918873 |
155 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.84666809 |
156 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.84464283 |
157 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84135119 |
158 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.82943740 |
159 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.81767396 |
160 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81413362 |
161 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81083320 |
162 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.80976151 |
163 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.79869007 |
164 | AR_19668381_ChIP-Seq_PC3_Human | 0.79682732 |
165 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78858955 |
166 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.78816534 |
167 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78686506 |
168 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78610923 |
169 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.78602465 |
170 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.78580323 |
171 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.78507379 |
172 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.78493125 |
173 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.78168075 |
174 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.74825398 |
175 | TP53_16413492_ChIP-PET_HCT116_Human | 0.74759204 |
176 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.74295527 |
177 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.74188933 |
178 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.73730122 |
179 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.73705243 |
180 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.73503901 |
181 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.73455209 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.63340799 |
2 | MP0005360_urolithiasis | 5.87140789 |
3 | MP0005365_abnormal_bile_salt | 5.77848779 |
4 | MP0008057_abnormal_DNA_replication | 5.49355253 |
5 | MP0005085_abnormal_gallbladder_physiolo | 4.87506195 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.65062483 |
7 | MP0003252_abnormal_bile_duct | 3.43177464 |
8 | MP0010234_abnormal_vibrissa_follicle | 3.29998599 |
9 | MP0010329_abnormal_lipoprotein_level | 3.13092043 |
10 | MP0004084_abnormal_cardiac_muscle | 2.83506326 |
11 | MP0010094_abnormal_chromosome_stability | 2.80911055 |
12 | MP0004147_increased_porphyrin_level | 2.78895961 |
13 | MP0004130_abnormal_muscle_cell | 2.67782725 |
14 | MP0001666_abnormal_nutrient_absorption | 2.38975234 |
15 | MP0003705_abnormal_hypodermis_morpholog | 2.37174159 |
16 | MP0004215_abnormal_myocardial_fiber | 2.25527446 |
17 | MP0008877_abnormal_DNA_methylation | 2.23802062 |
18 | MP0003646_muscle_fatigue | 2.14287185 |
19 | MP0004957_abnormal_blastocyst_morpholog | 2.12954915 |
20 | MP0003111_abnormal_nucleus_morphology | 2.11679694 |
21 | MP0002396_abnormal_hematopoietic_system | 2.10353820 |
22 | MP0005083_abnormal_biliary_tract | 2.06699263 |
23 | MP0000609_abnormal_liver_physiology | 2.05370611 |
24 | MP0010352_gastrointestinal_tract_polyps | 2.02186482 |
25 | MP0003806_abnormal_nucleotide_metabolis | 1.99839536 |
26 | MP0001849_ear_inflammation | 1.95879892 |
27 | MP0005332_abnormal_amino_acid | 1.92225347 |
28 | MP0002166_altered_tumor_susceptibility | 1.91322247 |
29 | MP0002118_abnormal_lipid_homeostasis | 1.89468872 |
30 | MP0003077_abnormal_cell_cycle | 1.88359226 |
31 | MP0009840_abnormal_foam_cell | 1.86576783 |
32 | MP0008058_abnormal_DNA_repair | 1.81315048 |
33 | MP0000749_muscle_degeneration | 1.81238102 |
34 | MP0003195_calcinosis | 1.76922100 |
35 | MP0004484_altered_response_of | 1.75445143 |
36 | MP0003693_abnormal_embryo_hatching | 1.74500131 |
37 | MP0003868_abnormal_feces_composition | 1.72030463 |
38 | MP0004381_abnormal_hair_follicle | 1.70818580 |
39 | MP0009697_abnormal_copulation | 1.69278962 |
40 | MP0003191_abnormal_cellular_cholesterol | 1.69208591 |
41 | MP0005075_abnormal_melanosome_morpholog | 1.63954002 |
42 | MP0008775_abnormal_heart_ventricle | 1.63602980 |
43 | MP0000372_irregular_coat_pigmentation | 1.63157068 |
44 | MP0004185_abnormal_adipocyte_glucose | 1.61058064 |
45 | MP0003787_abnormal_imprinting | 1.55242845 |
46 | MP0010307_abnormal_tumor_latency | 1.52630206 |
47 | MP0003221_abnormal_cardiomyocyte_apopto | 1.52511306 |
48 | MP0008961_abnormal_basal_metabolism | 1.51208129 |
49 | MP0003300_gastrointestinal_ulcer | 1.49715572 |
50 | MP0000569_abnormal_digit_pigmentation | 1.49476648 |
51 | MP0002837_dystrophic_cardiac_calcinosis | 1.46540900 |
52 | MP0002971_abnormal_brown_adipose | 1.46495813 |
53 | MP0003890_abnormal_embryonic-extraembry | 1.41250563 |
54 | MP0003718_maternal_effect | 1.40525958 |
55 | MP0001730_embryonic_growth_arrest | 1.40445332 |
56 | MP0004859_abnormal_synaptic_plasticity | 1.40136986 |
57 | MP0009780_abnormal_chondrocyte_physiolo | 1.38694672 |
58 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.37872473 |
59 | MP0000015_abnormal_ear_pigmentation | 1.36472009 |
60 | MP0004947_skin_inflammation | 1.35207210 |
61 | MP0005666_abnormal_adipose_tissue | 1.33799849 |
62 | MP0005187_abnormal_penis_morphology | 1.32183041 |
63 | MP0002796_impaired_skin_barrier | 1.29359851 |
64 | MP0010630_abnormal_cardiac_muscle | 1.27883012 |
65 | MP0010678_abnormal_skin_adnexa | 1.27340833 |
66 | MP0005451_abnormal_body_composition | 1.26019695 |
67 | MP0002822_catalepsy | 1.20633807 |
68 | MP0002909_abnormal_adrenal_gland | 1.20351446 |
69 | MP0002078_abnormal_glucose_homeostasis | 1.18788520 |
70 | MP0005330_cardiomyopathy | 1.18747450 |
71 | MP0002972_abnormal_cardiac_muscle | 1.18506824 |
72 | MP0004019_abnormal_vitamin_homeostasis | 1.16394696 |
73 | MP0002106_abnormal_muscle_physiology | 1.16311493 |
74 | MP0003123_paternal_imprinting | 1.14115656 |
75 | MP0004145_abnormal_muscle_electrophysio | 1.13736843 |
76 | MP0000747_muscle_weakness | 1.13456392 |
77 | MP0005319_abnormal_enzyme/_coenzyme | 1.10690399 |
78 | MP0002006_tumorigenesis | 1.10435469 |
79 | MP0002138_abnormal_hepatobiliary_system | 1.07478458 |
80 | MP0001697_abnormal_embryo_size | 1.06984799 |
81 | MP0005266_abnormal_metabolism | 1.06639700 |
82 | MP0005385_cardiovascular_system_phenoty | 1.06527177 |
83 | MP0001544_abnormal_cardiovascular_syste | 1.06527177 |
84 | MP0002088_abnormal_embryonic_growth/wei | 1.03581316 |
85 | MP0005620_abnormal_muscle_contractility | 1.03552202 |
86 | MP0003984_embryonic_growth_retardation | 1.03115969 |
87 | MP0003880_abnormal_central_pattern | 1.03086468 |
88 | MP0000604_amyloidosis | 1.02887096 |
89 | MP0005380_embryogenesis_phenotype | 1.02492583 |
90 | MP0001672_abnormal_embryogenesis/_devel | 1.02492583 |
91 | MP0005409_darkened_coat_color | 1.02277508 |
92 | MP0005334_abnormal_fat_pad | 1.01592305 |
93 | MP0009703_decreased_birth_body | 0.99836953 |
94 | MP0003567_abnormal_fetal_cardiomyocyte | 0.99662608 |
95 | MP0002876_abnormal_thyroid_physiology | 0.98502942 |
96 | MP0005375_adipose_tissue_phenotype | 0.98288771 |
97 | MP0006138_congestive_heart_failure | 0.97992469 |
98 | MP0004808_abnormal_hematopoietic_stem | 0.96592655 |
99 | MP0009643_abnormal_urine_homeostasis | 0.94442552 |
100 | MP0005535_abnormal_body_temperature | 0.94320250 |
101 | MP0003329_amyloid_beta_deposits | 0.94131741 |
102 | MP0000350_abnormal_cell_proliferation | 0.94054997 |
103 | MP0005171_absent_coat_pigmentation | 0.91474698 |
104 | MP0003656_abnormal_erythrocyte_physiolo | 0.89684708 |
105 | MP0002086_abnormal_extraembryonic_tissu | 0.88620129 |
106 | MP0008569_lethality_at_weaning | 0.87813895 |
107 | MP0008007_abnormal_cellular_replicative | 0.87724326 |
108 | MP0008260_abnormal_autophagy | 0.86797061 |
109 | MP0005174_abnormal_tail_pigmentation | 0.86740438 |
110 | MP0005408_hypopigmentation | 0.85898253 |
111 | MP0004043_abnormal_pH_regulation | 0.84995782 |
112 | MP0005369_muscle_phenotype | 0.84832507 |
113 | MP0004885_abnormal_endolymph | 0.83952210 |
114 | MP0000013_abnormal_adipose_tissue | 0.83025325 |
115 | MP0000751_myopathy | 0.82765054 |
116 | MP0003879_abnormal_hair_cell | 0.81616788 |
117 | MP0003635_abnormal_synaptic_transmissio | 0.80982026 |
118 | MP0000598_abnormal_liver_morphology | 0.80714126 |
119 | MP0005076_abnormal_cell_differentiation | 0.80679553 |
120 | MP0003121_genomic_imprinting | 0.80598189 |
121 | MP0000003_abnormal_adipose_tissue | 0.80013011 |
122 | MP0005647_abnormal_sex_gland | 0.78213412 |
123 | MP0005464_abnormal_platelet_physiology | 0.77601690 |
124 | MP0002638_abnormal_pupillary_reflex | 0.77407752 |
125 | MP0004197_abnormal_fetal_growth/weight/ | 0.75960020 |
126 | MP0004510_myositis | 0.75351029 |
127 | MP0006035_abnormal_mitochondrial_morpho | 0.75320449 |
128 | MP0002080_prenatal_lethality | 0.74648139 |
129 | MP0002269_muscular_atrophy | 0.74276930 |
130 | MP0003690_abnormal_glial_cell | 0.74044055 |
131 | MP0002877_abnormal_melanocyte_morpholog | 0.74020078 |
132 | MP0004264_abnormal_extraembryonic_tissu | 0.73029993 |
133 | MP0002102_abnormal_ear_morphology | 0.72967127 |
134 | MP0001188_hyperpigmentation | 0.72896490 |
135 | MP0005448_abnormal_energy_balance | 0.72543503 |
136 | MP0004085_abnormal_heartbeat | 0.70684360 |
137 | MP0000759_abnormal_skeletal_muscle | 0.70619185 |
138 | MP0008874_decreased_physiological_sensi | 0.69911017 |
139 | MP0004087_abnormal_muscle_fiber | 0.69870275 |
140 | MP0001486_abnormal_startle_reflex | 0.69535715 |
141 | MP0000703_abnormal_thymus_morphology | 0.67804508 |
142 | MP0001929_abnormal_gametogenesis | 0.66751113 |
143 | MP0003763_abnormal_thymus_physiology | 0.65903311 |
144 | MP0001661_extended_life_span | 0.65716935 |
145 | MP0002090_abnormal_vision | 0.65424591 |
146 | MP0003941_abnormal_skin_development | 0.65246590 |
147 | MP0002009_preneoplasia | 0.64739292 |
148 | MP0000383_abnormal_hair_follicle | 0.64698302 |
149 | MP0001944_abnormal_pancreas_morphology | 0.64495143 |
150 | MP0002084_abnormal_developmental_patter | 0.64207035 |
151 | MP0001756_abnormal_urination | 0.62823667 |
152 | MP0009672_abnormal_birth_weight | 0.61775440 |
153 | MP0000639_abnormal_adrenal_gland | 0.61444955 |
154 | MP0002132_abnormal_respiratory_system | 0.61392658 |
155 | MP0004270_analgesia | 0.61348516 |
156 | MP0002254_reproductive_system_inflammat | 0.61047500 |
157 | MP0000427_abnormal_hair_cycle | 0.60701958 |
158 | MP0004036_abnormal_muscle_relaxation | 0.60607623 |
159 | MP0001879_abnormal_lymphatic_vessel | 0.58953950 |
160 | MP0001765_abnormal_ion_homeostasis | 0.58707801 |
161 | MP0005220_abnormal_exocrine_pancreas | 0.58571513 |
162 | MP0009115_abnormal_fat_cell | 0.58506275 |
163 | MP0002970_abnormal_white_adipose | 0.55810584 |
164 | MP0003633_abnormal_nervous_system | 0.53046610 |
165 | MP0009642_abnormal_blood_homeostasis | 0.52852566 |
166 | MP0002063_abnormal_learning/memory/cond | 0.51439429 |
167 | MP0006036_abnormal_mitochondrial_physio | 0.50431158 |
168 | MP0003959_abnormal_lean_body | 0.50019019 |
169 | MP0005167_abnormal_blood-brain_barrier | 0.49810363 |
170 | MP0008770_decreased_survivor_rate | 0.49233658 |
171 | MP0003953_abnormal_hormone_level | 0.47821905 |
172 | MP0000920_abnormal_myelination | 0.47610865 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoplasia of the thymus (HP:0000778) | 5.37232969 |
2 | Deep venous thrombosis (HP:0002625) | 5.21322540 |
3 | T lymphocytopenia (HP:0005403) | 4.84649748 |
4 | Intrahepatic cholestasis (HP:0001406) | 4.72192818 |
5 | Abnormality of T cell number (HP:0011839) | 4.52579290 |
6 | B lymphocytopenia (HP:0010976) | 4.19212333 |
7 | Abnormality of B cell number (HP:0010975) | 4.19212333 |
8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.16060331 |
9 | Xanthomatosis (HP:0000991) | 4.14222127 |
10 | Papillary thyroid carcinoma (HP:0002895) | 3.96618873 |
11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.96225792 |
12 | Nemaline bodies (HP:0003798) | 3.83204666 |
13 | Hypobetalipoproteinemia (HP:0003563) | 3.81644785 |
14 | Thyroiditis (HP:0100646) | 3.79794741 |
15 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.75903332 |
16 | Subaortic stenosis (HP:0001682) | 3.75903332 |
17 | Muscle fiber inclusion bodies (HP:0100299) | 3.75902113 |
18 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.64153711 |
19 | Hyperlipoproteinemia (HP:0010980) | 3.61597970 |
20 | Bundle branch block (HP:0011710) | 3.58039282 |
21 | Severe combined immunodeficiency (HP:0004430) | 3.57746259 |
22 | Complement deficiency (HP:0004431) | 3.55516995 |
23 | Calf muscle hypertrophy (HP:0008981) | 3.30883260 |
24 | Combined immunodeficiency (HP:0005387) | 3.25755449 |
25 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.24285830 |
26 | Ketosis (HP:0001946) | 3.23632759 |
27 | Epidermoid cyst (HP:0200040) | 3.21335420 |
28 | Hypolipoproteinemia (HP:0010981) | 3.18818715 |
29 | Hypoalphalipoproteinemia (HP:0003233) | 3.13947906 |
30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.11734777 |
31 | Prolonged partial thromboplastin time (HP:0003645) | 3.10839984 |
32 | Hyperglycinemia (HP:0002154) | 3.06425052 |
33 | Panhypogammaglobulinemia (HP:0003139) | 3.04912486 |
34 | Hypochromic microcytic anemia (HP:0004840) | 3.04212610 |
35 | Hyperglycinuria (HP:0003108) | 3.01796213 |
36 | Hypoglycemic coma (HP:0001325) | 2.97486050 |
37 | Thyroid carcinoma (HP:0002890) | 2.96852697 |
38 | Sudden death (HP:0001699) | 2.95433542 |
39 | Hyperammonemia (HP:0001987) | 2.94458743 |
40 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.93887673 |
41 | Abnormality of glycine metabolism (HP:0010895) | 2.90904000 |
42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.90904000 |
43 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.89648208 |
44 | Chromsome breakage (HP:0040012) | 2.88794941 |
45 | Eosinophilia (HP:0001880) | 2.80568161 |
46 | Ketoacidosis (HP:0001993) | 2.74059816 |
47 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.73577029 |
48 | EMG: myopathic abnormalities (HP:0003458) | 2.72545207 |
49 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.71628983 |
50 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.66106275 |
51 | Abnormality of chromosome stability (HP:0003220) | 2.65630548 |
52 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.65380691 |
53 | Dysmetric saccades (HP:0000641) | 2.64006216 |
54 | Areflexia of lower limbs (HP:0002522) | 2.61071707 |
55 | Biliary tract neoplasm (HP:0100574) | 2.56031459 |
56 | Fat malabsorption (HP:0002630) | 2.55584283 |
57 | Embryonal renal neoplasm (HP:0011794) | 2.51150882 |
58 | Erythroderma (HP:0001019) | 2.50710676 |
59 | Hypoproteinemia (HP:0003075) | 2.42458661 |
60 | Neoplasm of the adrenal gland (HP:0100631) | 2.42048062 |
61 | Recurrent viral infections (HP:0004429) | 2.41685790 |
62 | Exercise-induced myalgia (HP:0003738) | 2.40348973 |
63 | Hypercholesterolemia (HP:0003124) | 2.39632286 |
64 | Gout (HP:0001997) | 2.36707015 |
65 | Volvulus (HP:0002580) | 2.34717451 |
66 | EMG: neuropathic changes (HP:0003445) | 2.33697796 |
67 | Acanthocytosis (HP:0001927) | 2.32121971 |
68 | Hepatocellular carcinoma (HP:0001402) | 2.30596805 |
69 | Abnormality of complement system (HP:0005339) | 2.30195422 |
70 | Neoplasm of the small intestine (HP:0100833) | 2.29750437 |
71 | Conjugated hyperbilirubinemia (HP:0002908) | 2.26752236 |
72 | Cystic hygroma (HP:0000476) | 2.26674373 |
73 | Curly hair (HP:0002212) | 2.26444673 |
74 | Spastic diplegia (HP:0001264) | 2.25615480 |
75 | Rimmed vacuoles (HP:0003805) | 2.23627371 |
76 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.21530818 |
77 | Progressive external ophthalmoplegia (HP:0000590) | 2.20621727 |
78 | Neoplasm of the adrenal cortex (HP:0100641) | 2.20407909 |
79 | Heart block (HP:0012722) | 2.19872190 |
80 | Myocardial infarction (HP:0001658) | 2.18419903 |
81 | Joint hemorrhage (HP:0005261) | 2.18130881 |
82 | Long clavicles (HP:0000890) | 2.17778497 |
83 | Poikilocytosis (HP:0004447) | 2.16654148 |
84 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.15837320 |
85 | Abnormality of the intrinsic pathway (HP:0010989) | 2.15239840 |
86 | Macroorchidism (HP:0000053) | 2.14162072 |
87 | Pheochromocytoma (HP:0002666) | 2.13676388 |
88 | Abnormality of the Achilles tendon (HP:0005109) | 2.12780705 |
89 | Abnormal biliary tract morphology (HP:0012440) | 2.12073610 |
90 | Abnormality of the calf musculature (HP:0001430) | 2.10087702 |
91 | Acute myeloid leukemia (HP:0004808) | 2.10024877 |
92 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.09801854 |
93 | Gastrointestinal carcinoma (HP:0002672) | 2.09801854 |
94 | Abnormality of methionine metabolism (HP:0010901) | 2.08960824 |
95 | Rhabdomyosarcoma (HP:0002859) | 2.08884666 |
96 | Skin nodule (HP:0200036) | 2.08826874 |
97 | Hyporeflexia of lower limbs (HP:0002600) | 2.08610145 |
98 | Hyperglycemia (HP:0003074) | 2.08196005 |
99 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.08163721 |
100 | Abnormality of purine metabolism (HP:0004352) | 2.07498523 |
101 | Action tremor (HP:0002345) | 2.06918037 |
102 | Status epilepticus (HP:0002133) | 2.06210759 |
103 | Abnormality of the lower motor neuron (HP:0002366) | 2.06033525 |
104 | Bladder neoplasm (HP:0009725) | 2.05199511 |
105 | Bladder carcinoma (HP:0002862) | 2.05199511 |
106 | Ovarian neoplasm (HP:0100615) | 2.03839058 |
107 | Hyperbilirubinemia (HP:0002904) | 2.03723489 |
108 | Febrile seizures (HP:0002373) | 2.03160602 |
109 | Abnormality of chromosome segregation (HP:0002916) | 2.03105115 |
110 | Cholelithiasis (HP:0001081) | 2.00462928 |
111 | Granulocytopenia (HP:0001913) | 1.98923082 |
112 | Neonatal hypoglycemia (HP:0001998) | 1.98085980 |
113 | Muscle fiber splitting (HP:0003555) | 1.97224715 |
114 | Intention tremor (HP:0002080) | 1.97007307 |
115 | Exercise-induced muscle cramps (HP:0003710) | 1.96770155 |
116 | Hypoglycemic seizures (HP:0002173) | 1.95203244 |
117 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94790533 |
118 | Abnormal gallbladder morphology (HP:0012437) | 1.93820459 |
119 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.92327624 |
120 | Myoglobinuria (HP:0002913) | 1.92262660 |
121 | Pseudobulbar signs (HP:0002200) | 1.90873552 |
122 | Global brain atrophy (HP:0002283) | 1.90072024 |
123 | Frequent falls (HP:0002359) | 1.89472905 |
124 | Myelodysplasia (HP:0002863) | 1.89388538 |
125 | Abnormality of eosinophils (HP:0001879) | 1.89163934 |
126 | Impaired social interactions (HP:0000735) | 1.89160218 |
127 | Abnormal social behavior (HP:0012433) | 1.89160218 |
128 | Spontaneous abortion (HP:0005268) | 1.89004968 |
129 | Embryonal neoplasm (HP:0002898) | 1.88673286 |
130 | Rhabdomyolysis (HP:0003201) | 1.86402954 |
131 | Abnormality of the preputium (HP:0100587) | 1.86292116 |
132 | Uterine leiomyosarcoma (HP:0002891) | 1.84683594 |
133 | Leiomyosarcoma (HP:0100243) | 1.84683594 |
134 | Dyschromatopsia (HP:0007641) | 1.84649487 |
135 | Cafe-au-lait spot (HP:0000957) | 1.84052449 |
136 | Ventricular tachycardia (HP:0004756) | 1.83080740 |
137 | Esophageal varix (HP:0002040) | 1.82520942 |
138 | Breast carcinoma (HP:0003002) | 1.81745297 |
139 | Ependymoma (HP:0002888) | 1.81741007 |
140 | Right ventricular cardiomyopathy (HP:0011663) | 1.81497070 |
141 | Blue irides (HP:0000635) | 1.81423965 |
142 | Atrioventricular block (HP:0001678) | 1.81141413 |
143 | Neonatal onset (HP:0003623) | 1.80979876 |
144 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.80027839 |
145 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.79279600 |
146 | Neoplasm of the thyroid gland (HP:0100031) | 1.78866621 |
147 | Termporal pattern (HP:0011008) | 1.78680341 |
148 | Insidious onset (HP:0003587) | 1.78680341 |
149 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.78582117 |
150 | Uterine neoplasm (HP:0010784) | 1.78395804 |
151 | Abnormality of the fingertips (HP:0001211) | 1.78181574 |
152 | Difficulty running (HP:0009046) | 1.77732477 |
153 | Delayed CNS myelination (HP:0002188) | 1.77585861 |
154 | Neuroendocrine neoplasm (HP:0100634) | 1.76469127 |
155 | Acute hepatic failure (HP:0006554) | 1.75157046 |
156 | Back pain (HP:0003418) | 1.75058647 |
157 | Abnormality of nucleobase metabolism (HP:0010932) | 1.74840722 |
158 | Abnormality of the astrocytes (HP:0100707) | 1.74654827 |
159 | Astrocytoma (HP:0009592) | 1.74654827 |
160 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.73490348 |
161 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.73490348 |
162 | Symptomatic seizures (HP:0011145) | 1.73473618 |
163 | Abnormal atrioventricular conduction (HP:0005150) | 1.72449554 |
164 | Visual hallucinations (HP:0002367) | 1.72412719 |
165 | Hyperkalemia (HP:0002153) | 1.72218136 |
166 | Ventricular fibrillation (HP:0001663) | 1.70417571 |
167 | Medulloblastoma (HP:0002885) | 1.70296027 |
168 | Resting tremor (HP:0002322) | 1.69690300 |
169 | Gaze-evoked nystagmus (HP:0000640) | 1.69431290 |
170 | Sensorimotor neuropathy (HP:0007141) | 1.69306238 |
171 | Neoplasm of the colon (HP:0100273) | 1.68688981 |
172 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.67972795 |
173 | Abnormal auditory evoked potentials (HP:0006958) | 1.67683741 |
174 | Tetraplegia (HP:0002445) | 1.67418362 |
175 | Abnormality of T cells (HP:0002843) | 1.66584540 |
176 | Achilles tendon contracture (HP:0001771) | 1.65801496 |
177 | Reticulocytosis (HP:0001923) | 1.64584585 |
178 | Polycythemia (HP:0001901) | 1.61884096 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EIF2AK1 | 3.49567163 |
2 | EIF2AK3 | 3.27684496 |
3 | TRIB3 | 2.96341954 |
4 | PKN2 | 2.76887512 |
5 | FGFR2 | 2.65005857 |
6 | MAP3K7 | 2.33449296 |
7 | PLK3 | 2.19297370 |
8 | LATS1 | 2.16965782 |
9 | RIPK1 | 2.00379747 |
10 | SIK1 | 1.99937004 |
11 | TTK | 1.97193167 |
12 | PTK6 | 1.96808826 |
13 | FGFR4 | 1.96134350 |
14 | KSR2 | 1.94319920 |
15 | FRK | 1.92241416 |
16 | MAP2K4 | 1.89073659 |
17 | BRSK2 | 1.82499659 |
18 | PLK2 | 1.78906291 |
19 | STK24 | 1.78192182 |
20 | CAMKK1 | 1.76676554 |
21 | MST4 | 1.75645267 |
22 | BRD4 | 1.73459144 |
23 | MAP3K2 | 1.68230360 |
24 | CAMKK2 | 1.65873949 |
25 | PDGFRB | 1.64307239 |
26 | BCKDK | 1.63502384 |
27 | MKNK2 | 1.62859990 |
28 | ZAK | 1.61573419 |
29 | TAOK3 | 1.60593604 |
30 | CAMK1G | 1.59309166 |
31 | CAMK1D | 1.57605393 |
32 | RET | 1.57364856 |
33 | MAP3K10 | 1.55746722 |
34 | CDC7 | 1.54661907 |
35 | EEF2K | 1.54110506 |
36 | DAPK2 | 1.52117547 |
37 | BUB1 | 1.45850240 |
38 | NUAK1 | 1.42562799 |
39 | FGFR3 | 1.41617716 |
40 | NLK | 1.40942944 |
41 | TYRO3 | 1.37197120 |
42 | SGK3 | 1.35803531 |
43 | ACVR1B | 1.35209169 |
44 | INSRR | 1.34557217 |
45 | MAP3K9 | 1.33463295 |
46 | MAP3K4 | 1.33382527 |
47 | PDGFRA | 1.30125180 |
48 | TSSK6 | 1.29097580 |
49 | CDK12 | 1.28322374 |
50 | PLK4 | 1.25265293 |
51 | MAPK7 | 1.22205424 |
52 | PAK6 | 1.20680593 |
53 | STK38 | 1.20336476 |
54 | CDK6 | 1.19975103 |
55 | JAK2 | 1.18507244 |
56 | ERBB3 | 1.16316569 |
57 | SRPK1 | 1.15305379 |
58 | MKNK1 | 1.13778175 |
59 | NTRK3 | 1.13095283 |
60 | PRKCH | 1.12319009 |
61 | NEK6 | 1.11890747 |
62 | STK4 | 1.11057230 |
63 | CSNK1G2 | 1.06702047 |
64 | OXSR1 | 0.99840130 |
65 | CSNK1A1L | 0.98321148 |
66 | AKT3 | 0.98083535 |
67 | IRAK2 | 0.96269596 |
68 | RAF1 | 0.95763359 |
69 | MAPK12 | 0.95173324 |
70 | STK39 | 0.94749722 |
71 | GRK6 | 0.94704383 |
72 | KSR1 | 0.94650923 |
73 | TAOK1 | 0.93216793 |
74 | ERN1 | 0.92432999 |
75 | TTN | 0.92214313 |
76 | WNK1 | 0.90363436 |
77 | ITK | 0.89418193 |
78 | PRKAA1 | 0.87295698 |
79 | RPS6KB1 | 0.87238786 |
80 | ATM | 0.86930927 |
81 | EPHA4 | 0.86162600 |
82 | PDK1 | 0.85567596 |
83 | STK38L | 0.84502911 |
84 | MARK2 | 0.80526842 |
85 | TRIM28 | 0.80497046 |
86 | MAPK11 | 0.80368457 |
87 | SCYL2 | 0.80054770 |
88 | PLK1 | 0.78221458 |
89 | NTRK2 | 0.77437186 |
90 | SGK2 | 0.77038056 |
91 | RIPK4 | 0.76653141 |
92 | WEE1 | 0.76404009 |
93 | PAK3 | 0.75310677 |
94 | PDPK1 | 0.74978644 |
95 | FGFR1 | 0.74249886 |
96 | MAP3K1 | 0.73777273 |
97 | ERBB2 | 0.72961303 |
98 | TXK | 0.71599907 |
99 | ATR | 0.71146041 |
100 | TRPM7 | 0.70617852 |
101 | CSNK1G1 | 0.70471806 |
102 | NEK1 | 0.70032376 |
103 | IRAK1 | 0.69261198 |
104 | RPS6KB2 | 0.69081879 |
105 | LMTK2 | 0.67983060 |
106 | PRKD1 | 0.67838568 |
107 | PHKG2 | 0.67123072 |
108 | PHKG1 | 0.67123072 |
109 | ALK | 0.66761457 |
110 | PRKAA2 | 0.65999632 |
111 | SIK2 | 0.64128885 |
112 | CAMK1 | 0.63450319 |
113 | MAP2K3 | 0.63034450 |
114 | FER | 0.62833262 |
115 | HIPK2 | 0.62694472 |
116 | PRKCQ | 0.62324158 |
117 | PIM1 | 0.62064388 |
118 | JAK1 | 0.61879501 |
119 | STK11 | 0.61704511 |
120 | TEC | 0.61400745 |
121 | MTOR | 0.61397497 |
122 | DYRK1A | 0.61023337 |
123 | CDK3 | 0.60455740 |
124 | CAMK4 | 0.60307371 |
125 | ERBB4 | 0.58811558 |
126 | CSNK1G3 | 0.58405308 |
127 | YES1 | 0.57675620 |
128 | EPHB1 | 0.57188463 |
129 | FLT3 | 0.56952005 |
130 | STK3 | 0.56846450 |
131 | MAP3K6 | 0.56578098 |
132 | TNIK | 0.56573624 |
133 | OBSCN | 0.56255955 |
134 | PDK3 | 0.55700305 |
135 | PDK4 | 0.55700305 |
136 | DMPK | 0.55378047 |
137 | BRSK1 | 0.55156027 |
138 | PBK | 0.55132477 |
139 | LATS2 | 0.54908231 |
140 | SGK223 | 0.54889862 |
141 | SGK494 | 0.54889862 |
142 | DYRK1B | 0.54708945 |
143 | PIK3CA | 0.53438013 |
144 | MAPK10 | 0.53335124 |
145 | SGK1 | 0.53095770 |
146 | CSNK1D | 0.52549414 |
147 | BRAF | 0.52259889 |
148 | MINK1 | 0.52211889 |
149 | PIK3CG | 0.51751426 |
150 | CSK | 0.51162211 |
151 | ICK | 0.50980688 |
152 | TYK2 | 0.50839268 |
153 | MARK3 | 0.50333806 |
154 | EIF2AK2 | 0.48829435 |
155 | CHEK1 | 0.46103128 |
156 | CCNB1 | 0.43323970 |
157 | PRPF4B | 0.43318632 |
158 | CSNK1E | 0.40201059 |
159 | MAP3K5 | 0.39743636 |
160 | PNCK | 0.39614402 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.58211007 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.48955092 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29391694 |
4 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.09198677 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.93360656 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.54085014 |
7 | Mismatch repair_Homo sapiens_hsa03430 | 2.25706160 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.14717772 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.12830893 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.02075778 |
11 | Cell cycle_Homo sapiens_hsa04110 | 1.98339201 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98194741 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93832853 |
14 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.92729012 |
15 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.86309175 |
16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.79334723 |
17 | Bile secretion_Homo sapiens_hsa04976 | 1.78118354 |
18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.77132380 |
19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76759698 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69548205 |
21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59080486 |
22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58846155 |
23 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.58784339 |
24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58365527 |
25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.55943351 |
26 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.54203619 |
27 | DNA replication_Homo sapiens_hsa03030 | 1.50033508 |
28 | Lysine degradation_Homo sapiens_hsa00310 | 1.45153199 |
29 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.43273888 |
30 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.42330438 |
31 | RNA transport_Homo sapiens_hsa03013 | 1.27721844 |
32 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.26882174 |
33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22965158 |
34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21411116 |
35 | ABC transporters_Homo sapiens_hsa02010 | 1.20269271 |
36 | Peroxisome_Homo sapiens_hsa04146 | 1.19642819 |
37 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.18526470 |
38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17155728 |
39 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.11354293 |
40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10425100 |
41 | RNA degradation_Homo sapiens_hsa03018 | 1.08746430 |
42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.07937684 |
43 | Alcoholism_Homo sapiens_hsa05034 | 1.07740064 |
44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02997495 |
45 | Insulin resistance_Homo sapiens_hsa04931 | 1.02283819 |
46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01986450 |
47 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.00890077 |
48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99695350 |
49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96929321 |
50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95283594 |
51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94920853 |
52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.94891373 |
53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94169582 |
54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94048515 |
55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92538158 |
56 | Long-term depression_Homo sapiens_hsa04730 | 0.91069139 |
57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90287988 |
58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89918105 |
59 | Platelet activation_Homo sapiens_hsa04611 | 0.86646436 |
60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86437854 |
61 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84229779 |
62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83587675 |
63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.83503896 |
64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82750523 |
65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82737305 |
66 | Retinol metabolism_Homo sapiens_hsa00830 | 0.82460424 |
67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82035677 |
68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81995932 |
69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81266895 |
70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78875059 |
71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78232713 |
72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77989397 |
73 | Long-term potentiation_Homo sapiens_hsa04720 | 0.77987444 |
74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77365520 |
75 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74623378 |
76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74264728 |
77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73303323 |
78 | Homologous recombination_Homo sapiens_hsa03440 | 0.72839293 |
79 | Prostate cancer_Homo sapiens_hsa05215 | 0.72229471 |
80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71904171 |
81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69883054 |
82 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.69602893 |
83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69203441 |
84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68989731 |
85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68710079 |
86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66528899 |
87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66345562 |
88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65646899 |
89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64204633 |
90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64138124 |
91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.63712026 |
92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59595380 |
93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59511583 |
94 | Adherens junction_Homo sapiens_hsa04520 | 0.58703876 |
95 | Tight junction_Homo sapiens_hsa04530 | 0.57926302 |
96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57790183 |
97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57174847 |
98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55900117 |
99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52492804 |
100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52109699 |
101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51620434 |
102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51289646 |
103 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.51063912 |
104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51060668 |
105 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50992398 |
106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50821431 |
107 | Renin secretion_Homo sapiens_hsa04924 | 0.49766326 |
108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48925270 |
109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48902330 |
110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48612000 |
111 | Salivary secretion_Homo sapiens_hsa04970 | 0.47925039 |
112 | Insulin secretion_Homo sapiens_hsa04911 | 0.47160008 |
113 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46552552 |
114 | GABAergic synapse_Homo sapiens_hsa04727 | 0.45937298 |
115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45688066 |
116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45513119 |
117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45241022 |
118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44948388 |
119 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.44805657 |
120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44565065 |
121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.44402571 |
122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44346374 |
123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43449902 |
124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42876705 |
125 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.41975133 |
126 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.41787665 |
127 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41509739 |
128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40810991 |
129 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40131048 |
130 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.40006334 |
131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37336291 |
132 | Glioma_Homo sapiens_hsa05214 | 0.35913984 |
133 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34629139 |
134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34497920 |
135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33004668 |
136 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.31188972 |
137 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31073607 |
138 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30910580 |
139 | Circadian entrainment_Homo sapiens_hsa04713 | 0.30852271 |
140 | Olfactory transduction_Homo sapiens_hsa04740 | 0.30696308 |